Standard Chartered Posts Higher Profit on Trading Gains

The London-based bank posted a rise in first-quarter net profit due to higher trading income despite lower earnings from lending. 


 
Rio Tinto Declines Comment on Whether Considering Rival Anglo American Bid

The chair of Rio Tinto declined to comment on whether the world's second-largest miner by market value is weighing a bid for Anglo American, the target of a recent $39 billion bid by BHP Group. 


 
Microsoft to Invest $2.2 Billion in AI Infrastructure in Malaysia

The U.S. tech giant's investment over four years will build on previously announced plans to construct its first data center region in Malaysia, and mark its single biggest investment in the country. 


 
DBS Earnings Beat Expectations

Singapore's biggest bank by assets said its first-quarter net profit rose on higher fee and commission income, and expects to deliver strong shareholder returns this year 


 
NAB's Profit Falls; Increases Share Buyback

Australia's second-largest lender by market capitalization reported a 12% decline in half-year net profit and announced it will increase its share buyback by $980 million. 


 
NIO Shares Jump After Strong Sales Amid EV Price War

The Chinese electric-vehicle maker's shares are on track for their largest one-day gain in more than two years. 


 
Ex-Pioneer CEO Barred From Exxon Board for Megadeal to Close

Antitrust enforcers are set to allege former Pioneer CEO Scott Sheffield discussed coordinating oil-production levels with other producers and OPEC. 


 
UnitedHealth Under Fire in Congressional Hearings Over Cyberattack

Congress aggressively questioned UnitedHealth Group's response to the hack of its Change Healthcare unit in hearings Wednesday. 


 
Tesla's Downsizing Worries Supercharger Industry

Widespread layoffs within the Tesla unit are a blow to efforts to build out a national charging network. 


 
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities

Emergent BioSolutions is closing several manufacturing facilities and cutting hundreds of jobs as part of a restructuring as the company narrows its focus on products, including Narcan nasal spray.


(END) Dow Jones Newswires

05-02-24 0115ET